首页> 美国卫生研究院文献>British Journal of Sports Medicine >Prognosis in myocardial infarction--the benefits of exercise as seen in non-randomised trials.
【2h】

Prognosis in myocardial infarction--the benefits of exercise as seen in non-randomised trials.

机译:心肌梗塞的预后-在非随机试验中看到的运动益处。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous uncontrolled studies suggest that exercise rehabilitation reduces recurrence rates in post-myocardial infarction patients. Six hundred and ten consecutive post-coronary patients referred to an exercise rehabilitation programme have been followed for an average of 36.5 months (1-8 years). Total deaths amounted to 36 (1.89% p.a.) of which 23 were cardiac deaths, with an annual death rate averaging only 0.85% after the first year of conditioning had been completed. There were also a total of 21 non-fatal recurrences of infarction. comparison has been made with 700 patients enrolled in the Health Insurance Plan of New York. On the basis of smoothed probabilities for the risk factors reported in the New York series, we should have seen 89 deaths (P less than 0.001). Correcting for differences between the two groups (age and number of diabetics) gives a predicted mortality for the Toronto series of 63.5 deaths (3.42% p.a.). This discrepancy in favour of the exercised group is significant in terms of an infinitely large control population (P less than 0.001) and also sample sizes of 610 exercised and 700 control patients (0.01 greater than P greater than 0.001). Unfortunately, formally to prove such a 45% reduction in mortality by way of a randomised control trial would be extremely costly, possibly prohibitively so.
机译:先前的非对照研究表明,运动康复可以降低心肌梗死后患者的复发率。连续对610名冠心病患者进行了运动康复计划的随访,平均时间为36.5个月(1-8年)。总死亡人数为36(每年1.89%),其中因心脏死亡的人数为23,在完成第一年的调节后,年平均死亡率仅为0.85%。共有21例非致命性梗死复发。将纽约健康保险计划中的700名患者进行了比较。根据纽约系列中报告的风险因素的平滑概率,我们应该看到89例死亡(P小于0.001)。校正两组之间的差异(糖尿病患者的年龄和人数),得出多伦多系列63.5例死亡的预测死亡率(每年3.42%)。就无限大的对照人群(P小于0.001)以及610名运动和700例对照患者(0.01大于P大于0.001)的样本量而言,这种对运动组的支持意义重大。不幸的是,通过随机对照试验来正式证明死亡率降低了45%将会是极其昂贵的,甚至可能会让人望而却步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号